ArticleCellular oncology (Dordrecht, Netherlands)2021

The potent AMPK inhibitor BAY-3827 shows strong efficacy in androgen-dependent prostate cancer models.

Clara Lemos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.